Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Ophthalmology

Is Stem Cell Therapy Safe for Retinitis Pigmentosa?

At a Glance

There are currently no approved stem cell cures for retinitis pigmentosa (RP). Unregulated clinics aggressively market unproven, expensive treatments that can cause catastrophic vision loss and total blindness. You should never pursue fee-for-service stem cell injections for RP.

No, you should not pursue unregulated, fee-for-service stem cell therapy for retinitis pigmentosa (RP). When you are facing the terrifying prospect of losing your vision, it is completely understandable to want to try anything to save your sight. Predatory clinics understand this desperation and aggressively market unproven, dangerous injections [1][2]. However, there are currently no approved stem cell cures for RP available for purchase [3]. Patients who have paid for these unproven treatments have suffered permanent, catastrophic vision loss [4]. Always consult your treating ophthalmologist or retina specialist before pursuing any experimental therapy.

The Severe Dangers of Unregulated Stem Cell Clinics

A growing industry of “stem cell tourism” operates globally and within regulatory loopholes in the United States, targeting patients with degenerative diseases like RP [5][6]. These businesses offer unproven procedures that have not been validated for safety or effectiveness [7][8].

The physical risks of these unregulated treatments are severe. In a well-documented medical case, three patients received intravitreal (inside the eye) injections of “stem cells” derived from their own fat tissue at an unproven clinic [4]. All three patients suffered catastrophic complications, including retinal detachment (the retina pulling away from the back of the eye), severe bleeding in the eye, and dangerous pressure spikes [4]. Their vision deteriorated rapidly, with some patients progressing to total blindness (no light perception) within a year [4].

Red Flags: Spotting Predatory Clinics

Because these clinics use scientific-sounding language, it can be difficult to distinguish them from legitimate medical research. Watch for these major warning signs:

  • They charge you for treatment: Legitimate clinical trials are funded by researchers or pharmaceutical companies and rarely charge the patient for the experimental drug or procedure (though routine care, like standard eye exams, may still be billed to your insurance) [1][9]. Predatory clinics often charge thousands of dollars as a “participation” or “service” fee [1].
  • They treat both eyes on the same day: In legitimate ophthalmic (eye) research, doctors only treat one eye at a time to ensure that if a severe complication occurs, the patient’s other eye is spared. Unregulated clinics frequently inject both eyes on the same day, which caused the bilateral total blindness in the documented cases [4].
  • They use unproven cell types: Dangerous clinics often extract your own fat or bone marrow, minimally process it at your bedside, and inject it into your eye [4]. Legitimate eye research typically uses highly specialized, meticulously manufactured cells [10].
  • They rely on patient testimonials: Instead of providing data from published, peer-reviewed clinical trials, unregulated clinics rely heavily on unverified patient videos and success stories [2].

The State of Legitimate Stem Cell Research for RP

Stem cell therapy remains a promising area of legitimate research for RP, but it is strictly investigational and should only be administered in a controlled clinical research setting [8][11].

Rigorous, FDA-approved clinical trials are currently evaluating specialized cells, such as human retinal progenitor cells (hRPCs) [12]. Early Phase 1 and Phase 2 trials have shown that these specific cells are generally safe and well-tolerated when implanted by specialized retinal surgeons [13][12]. However, these are early-stage studies designed primarily to test safety, and large-scale trials are still needed to prove whether they can effectively stop or reverse vision loss [8][14].

If you are interested in participating in legitimate research, start by consulting a specialist in inherited retinal diseases. You can also search for trials on databases like ClinicalTrials.gov, but remain vigilant and apply the “red flags” checklist, as predatory clinics sometimes exploit these registries to appear legitimate. While waiting for these therapies to mature, work closely with your care team to manage your condition and maximize your remaining vision through proven supportive strategies.

Common questions in this guide

Is there an approved stem cell cure for retinitis pigmentosa?
Currently, there are no approved stem cell cures for retinitis pigmentosa available for purchase. While legitimate research is ongoing, any clinic claiming to offer a guaranteed cure is selling an unproven and potentially dangerous treatment.
What are the risks of unregulated stem cell treatments for eye diseases?
Unregulated treatments can cause severe, permanent damage. Documented complications from injecting unproven stem cells into the eye include retinal detachment, dangerous pressure spikes, severe bleeding, and rapid progression to total blindness.
How can I tell if a stem cell trial for RP is legitimate or a scam?
Legitimate trials rarely charge patients for the experimental treatment and typically only treat one eye at a time to minimize risk. Predatory clinics often charge thousands of dollars, treat both eyes on the same day, and rely on patient testimonials rather than published research.
What kind of legitimate stem cell research is being done for retinitis pigmentosa?
Legitimate researchers are conducting FDA-approved clinical trials using highly specialized cells, such as human retinal progenitor cells (hRPCs). These early-stage trials are primarily testing for safety and are administered by specialized retinal surgeons in strictly controlled settings.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are there any legitimate, FDA-approved clinical trials for RP that I might be a candidate for?
  2. 2.How can I verify that a clinical trial I find online is strictly regulated and safe?
  3. 3.What proactive steps can we take right now to maximize and protect my remaining vision while we wait for new treatments?
  4. 4.Can you refer me to a specialist in inherited retinal diseases who can help me navigate emerging therapies?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions.

    Turner L

    Cell stem cell 2021; (28(11)):1891-1895 doi:10.1016/j.stem.2021.10.008.

    PMID: 34739831
  2. 2

    Cash-Based Stem-Cell Clinics: The Modern Day Snake Oil Salesman? A Report of Two Cases of Patients Harmed by Intra-articular Stem Cell Injections.

    Taliaferro J, Shapiro SA, Montero DP, et al.

    JBJS case connector 2019; (9(4)):e0363 doi:10.2106/JBJS.CC.19.00363.

    PMID: 31815806
  3. 3

    Applications of Modern Cell Therapies: The Latest Data in Ophthalmology.

    Iliadis I, Pechnikova NA, Poimenidou M, et al.

    Life (Basel, Switzerland) 2025; (15(10)) doi:10.3390/life15101610.

    PMID: 41157282
  4. 4

    Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.

    Kuriyan AE, Albini TA, Townsend JH, et al.

    The New England journal of medicine 2017; (376(11)):1047-1053 doi:10.1056/NEJMoa1609583.

    PMID: 28296617
  5. 5

    Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study.

    Chavez J, Shah NA, Ruoss S, et al.

    Stem cell research & therapy 2021; (12(1)):189 doi:10.1186/s13287-021-02254-4.

    PMID: 33736697
  6. 6

    International stem cell tourism: a critical literature review and evidence-based recommendations.

    Lyons S, Salgaonkar S, Flaherty GT

    International health 2022; (14(2)):132-141 doi:10.1093/inthealth/ihab050.

    PMID: 34415026
  7. 7

    Clarifying Stem-Cell Therapy's Benefits and Risks.

    Marks PW, Witten CM, Califf RM

    The New England journal of medicine 2017; (376(11)):1007-1009 doi:10.1056/NEJMp1613723.

    PMID: 27959704
  8. 8

    Stem-cell regenerative medicine as applied to the penis.

    Pozzi E, Muneer A, Sangster P, et al.

    Current opinion in urology 2019; (29(4)):443-449 doi:10.1097/MOU.0000000000000636.

    PMID: 31008782
  9. 9

    The politics of evidence in online illness narratives: An analysis of crowdfunding for purported stem cell treatments.

    Tanner C, Munsie M, Sipp D, et al.

    Health (London, England : 1997) 2019; (23(4)):436-457 doi:10.1177/1363459319829194.

    PMID: 30782021
  10. 10

    Stem cell transplantation for the treatment of end-stage liver disease.

    Wu DB, Chen EQ, Tang H

    World journal of hepatology 2018; (10(12)):907-910 doi:10.4254/wjh.v10.i12.907.

    PMID: 30631395
  11. 11

    Advances in stem cell therapy for male stress urinary incontinence.

    Gallo F, Ninotta G, Schenone M, et al.

    Expert opinion on biological therapy 2019; (19(4)):293-300 doi:10.1080/14712598.2019.1578343.

    PMID: 30709326
  12. 12

    Immune Responses to Sequential Binocular Transplantation of Allogeneic Retinal Progenitor Cells to the Vitreous Cavity in Mice.

    Chen L, Yang J, Klassen H

    International journal of molecular sciences 2023; (24(7)) doi:10.3390/ijms24076205.

    PMID: 37047179
  13. 13

    Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients.

    Liu Y, Chen SJ, Li SY, et al.

    Stem cell research & therapy 2017; (8(1)):209 doi:10.1186/s13287-017-0661-8.

    PMID: 28962643
  14. 14

    Retinitis pigmentosa and stem cell therapy.

    Qi XY, Mi CH, Cao DR, et al.

    International journal of ophthalmology 2024; (17(7)):1363-1369 doi:10.18240/ijo.2024.07.22.

    PMID: 39026924

This information on experimental treatments for retinitis pigmentosa is for educational purposes only. Always consult your ophthalmologist or retina specialist before pursuing any investigational therapy or clinical trial.

Get notified when new evidence is published on Retinitis pigmentosa.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.